Latest "irbesartan amlodipine irbesartan Hypertension" News Stories

08:04 EST 7th February 2016 | BioPortfolio

Here are the most relevant search results for "irbesartan amlodipine irbesartan Hypertension" found in our extensive news archives from over 250 global news sources.

More Information about irbesartan amlodipine irbesartan Hypertension on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about irbesartan amlodipine irbesartan Hypertension for you to read. Along with our medical data and news we also list irbesartan amlodipine irbesartan Hypertension Clinical Trials, which are updated daily. BioPortfolio also has a large database of irbesartan amlodipine irbesartan Hypertension Companies for you to search.

Showing "irbesartan amlodipine irbesartan Hypertension" News Articles 1–25 of 911

Extremely Relevant

Propagermanium and irbesartan: Phase II started

Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure


Pulmonary Hypertension Association (PHA) Names ‘Periwinkle Pioneers’: Honor Recognizes 25 Years of Pulmonary Hypertension (PH) Advancements

Silver Spring, Md (PRWEB) November 25, 2015 In honor of Pulmonary Hypertension Awareness Month, the Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension (PH) patients and helping t...

Researchers boost hypertension treatment using unconventional approach

Using approved drugs in unconventional ways could help improve compliance in patients with hypertension, according to a study in The Journal of Clinical Hypertension.

Brain receptors targeted to treat inflammatory response and human hypertension

According to current statistics, hypertension affects more than 33% of US adults. Despite the availability of several antihypertensive medications, the morbidity and mortality caused by hypertension is on the rise, suggesting the need for investigation of novel signaling pathways involved in its pathogenesis.

Celecoxib/amlodipine besylate: Phase III data

Media Advisory: Results of New Research in High Blood Pressure Management Expected Today

MARKHAM, ONTARIO -- (Marketwired) -- 11/09/15 -- Results from the National Heart, Lung and Blood Institute (NHLBI) Systolic Blood Pressure Intervention Trial (SPRINT) will be presented at the American Heart Association's annual scientific meeting in Orlando, Florida this afternoon. SPRINT studied the results of controlling systolic blood pressure to a target of less than 120 millimeters of mercu...

Breakthrough discovery in cause, treatment and prevention of hypertension

Hypertension affects more than four million Australians but the cause of the disease has never been understood. In research published today and presented at an international scientific meeting this week in Vienna, Monash researchers reveal the cause of hypertension and how the disease could be reversed.

A General Cardiologist's Approach to Managing Hypertension

Dr Henry Black interviews Dr John Bisognano and discusses his approach to managing hypertension and treating resistant hypertension. Medscape Cardiology

Celecoxib/amlodipine besylate: Completed Phase III enrollment

Novel Therapeutics in Hypertension and Kidney Disease

Focus on two broad, important concepts emerging in the pharmacology and therapeutics of hypertension and kidney disease. Current Opinion in Nephrology and Hypertension

Hypertension in 2015: Resistant hypertension: impact and evolving treatment options

Combination therapy with optimal doses of multiple antihypertensive drugs fails to achieve blood pressure (BP) control in up to 15% of hypertensive patients. Key studies in 2015 highlighted the risks of uncontrolled hypertension and evaluated new therapeutic modalities designed to achieve satisfactory BP control in patients with treatment-resistant hypertension.

Scientists identify potential therapeutic target for pulmonary hypertension

Cardiovascular diseases are the leading cause of death worldwide. As a prime example, pulmonary hypertension is especially lethal, with one-half of patients dying within three years of being diagnosed. Yale researchers have uncovered a novel cell type that is essential to the development of pulmonary hypertension and promises to lead to improved therapies.

Novartis launches new hypertension program in Ghana

The Novartis Foundation and its partners have begun screening patients in a Community-based Hypertension Improvement Project (ComHIP) in Ghana in a two-year program designed to evaluate the impact of an innovative healthcare model on hypertension management and control. With the new healthcare model, Novartis and its partners aim to evaluate the impact of innovative healthcare and improve the cont...

Hypertension: Benefits of strict blood-pressure lowering in hypertension

A new meta-analysis by Ettehad and colleagues, which included >613,000 patients with hypertension from randomized, controlled trials, clearly demonstrates that antihypertensive medication reduces cardiovascular events and death in all patients, including those with systolic blood pressure

New Guidelines Focus on Pulmonary Hypertension in Kids

TUESDAY, Nov. 3, 2015 -- The first guidelines for diagnosis and treatment of pulmonary hypertension in children have been released by the American Heart Association and the American Thoracic Society. Pulmonary hypertension is a sometimes fatal...

Kitov Pharmaceuticals Reports Additional Data from its Phase III Trial on the Beneficial Blood Pressure Effects of KIT-302

TEL AVIV, Israel, Dec. 17, 2015 /PRNewswire/ -- Kitov Pharmaceuticals (NASDAQ/TASE: KTOV), an innovative biopharmaceutical company focused on late-stage drug development, today announced more data from its successfully concluded Phase III trial for its lead drug candidate, KIT-302. Data showed the favorable blood pressure effects of KIT-302 were present in all blood pressure variables measured in ...

Exercise Appears Safe, Helpful for Pulmonary Hypertension

FRIDAY, Sept. 4, 2015 -- Exercise can be beneficial and safe for people with pulmonary hypertension, researchers report. Pulmonary hypertension is a type of high blood pressure that affects the lungs and heart, causing breathing problems, fatigue...

Severe uncontrolled hypertension contraindicated with Betmiga

Severe uncontrolled hypertension is now listed as a contraindication in the summary of product characteristics for Betmiga (mirabegron; Astellas). Blood pressure should be measured before starting treatment and monitored regularly during treatment, especially in patients with hypertension.

Identification of phenotypes at risk of transition from diastolic hypertension to isolated systolic hypertension

Pharmacists help patients with hypertension

If you have hypertension, it pays to include a pharmacist in a medical care team.

Hypertension: PATHWAY to improving the treatment of drug-resistant hypertension

From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency

Risk of Renal, CV and Mortality Outcomes in Hypertension

Which hidden risks are the most likely to be lurking for patients with hypertension? Kidney International

Clinical factors associated with readmission for postpartum hypertension in women with pregnancy-related hypertension: a nested case control study

Quick Search

News Quicklinks